Hyperactivation of AKT is detected in most NSCLC cell lines [15]–[17], and in 30–75% NSCLCs [18]–[22] and promotes resistance to chemotherapy and radiation therapy [16]. Here, AKT1 is linked to non-small cell lung carcinoma.